Leonard Vernon
Geen lopende functies
Loopbaan van Leonard Vernon
Eerdere bekende functies van Leonard Vernon
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
YM BioSciences, Inc.
 YM BioSciences, Inc. Pharmaceuticals: MajorHealth Technology YM BioSciences, Inc. operates as a drug development company, which manufactures advancing hematology and cancer-related products. It is currently advancing in late-stage products, which include CYT387, an oral small molecule inhibitor of the kinase enzymes JAK1 and JAK2; and Nimotuzumab, an EGFR targeting humanized monoclonal antibody. The company was founded in 1994 and is headquartered in Mississauga, Canada. | Hoofd Administratief Officier | 17-01-2011 | - |
| Financieel Directeur/CFO | 17-01-2011 | - | |
MTS Allstream, Inc.
 MTS Allstream, Inc. Specialty TelecommunicationsCommunications MTS Allstream, Inc. provides communication and information technology solutions. It provides wire-line voice, high-speed Internet and data, wireless, directory, digital television, security, and alarm monitoring services. The company serves residential and business customers in Manitoba. MTS Allstream was founded in 1983 and is headquartered in Winnipeg, Canada | Hoofd Administratief Officier | - | - |
| Financieel Directeur/CFO | - | - |
Statistieken
Internationaal
| Canada | 2 |
| Verenigd Koninkrijk | 2 |
Operationeel
| Chief Administrative Officer | 2 |
| Director of Finance/CFO | 2 |
Sectoraal
| Communications | 2 |
| Health Technology | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
MTS Allstream, Inc.
MTS Allstream, Inc. Specialty TelecommunicationsCommunications MTS Allstream, Inc. provides communication and information technology solutions. It provides wire-line voice, high-speed Internet and data, wireless, directory, digital television, security, and alarm monitoring services. The company serves residential and business customers in Manitoba. MTS Allstream was founded in 1983 and is headquartered in Winnipeg, Canada | Communications |
YM BioSciences, Inc.
YM BioSciences, Inc. Pharmaceuticals: MajorHealth Technology YM BioSciences, Inc. operates as a drug development company, which manufactures advancing hematology and cancer-related products. It is currently advancing in late-stage products, which include CYT387, an oral small molecule inhibitor of the kinase enzymes JAK1 and JAK2; and Nimotuzumab, an EGFR targeting humanized monoclonal antibody. The company was founded in 1994 and is headquartered in Mississauga, Canada. | Health Technology |
- Beurs
- Insiders
- Leonard Vernon
- Ervaring
